Citation

David J. Straus, M.D., Jenny Huang, M.S., Marcia A. Testa, M.P.H., Ph.D., Alexandra M. Levine, M.D., Lawrence D. Kaplan, M.D. Prognostic factors in the treatment of human immunodeficiency virus-associated non-Hodgkin's lymphoma: analysis of AIDS Clinical Trials Group protocol 142--low-dose versus standard-dose m-BACOD plus granulocyte-macrophage colony-stimulating factor. Journal of Clinical Oncology. 1998 Nov 01; 16(11):3601-6.

Citation

Genevieve Chene, Philippe Morlat, M.D., Catherine Leport, M.D., Richard Hafner, M.D., L. Dequae, I. Charreau, Jean-Pierre Aboulker, Ph.D., Benjamin J. Luft, M.D., Jean Aubertin, Jean-Louis Vilde, Roger Salamon. Intention-to-treat vs. on-treatment analyses of clinical trial data: experience from a study of pyrimethamine in the primary prophylaxis of toxoplasmosis in HIV-infected patients. ANRS 005/ACTG 154 trial group. Controlled Clinical Trials. 1998 Jun 01; 19(3):233-48.

Citation

Rhoda S. Sperling, M.D., David E. Shapiro, Ph.D., George D. McSherry, M.D., Paula Britto, M.S., Bethann Cunningham-Schrader, B.A., M.S., Mary Culnane, C.R.N.P., M.S., Robert W. Coombs, M.D., Ph.D., Gwendolyn B. Scott, M.D., Russell B. Van Dyke, M.D., William T. Shearer, M.D., Ph.D., Eleanor Jimenez, M.D., F.A.A.P., Clemente Diaz, M.D., Duane Harrison, M.D., Jean-Francois Delfraissy, M.D. Safety of the Maternal-Infant Zidovudine Regimen Utilized in the Pediatric AIDS Clinical Trial Group 076 Study. AIDS. 1998 Oct 01; 12(14):1805-13.

Citation

JS Lambert, J McNamara, SL Katz, T Fenton, MH Kang, TC VanCott, R Livingston, E Hawkins, J Moye, W Borkowsky, D Johnson, R Yogev, AM Duliege, Donald P. Francis, M.D., D.Sc., Anne A. Gershon, M.D., Diane W. Wara, M.D., Natasha L. Martin, Myron Levin, M.D., George D. McSherry, M.D., Gale Smith, Ph.D. Safety and Immunogenicity of HIV Recombinant Envelope Vaccines in HIV-infected Infants and Children. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 1998 Dec 15; 19(5):451-61.

Citation

Helen Kastrissios, J. R. Suarez, Scott M. Hammer, M.D., David Katzenstein, M.D., Terrence F. Blaschke, M.D. The extent of non-adherence in a large clinical trial using plasma dideoxynucleoside concentrations as a marker. AIDS. 1998 Dec 03; 12(17):2305-11.

Citation

John P.A. Ioannidis, M.D. Effect of the statistical significance of results on the time to completion and publication of randomized efficacy trials. The Journal of the American Medical Association. 1998 Jan 28; 279(4):281-6.

Citation

Lawrence D'Angelo, M.D., M.P.H., Jane C. Lindsey, Sc.D., Bonnie Zimmer, B.S., Mary Culnane, C.R.N.P., M.S., Donna Futterman, M.D. Attempting to Enhance the Enrollment of Adolescents into AIDS Clinical Trials: The Design of ACTG Protocol 220. AIDS Patient Care and STDs. 1998 Nov 01; 12(11):853-9.

Citation

Mark W. Kline, MD, Russell B. Van Dyke, MD, Jane C. Lindsey, ScD, Meg Gwynne, B.A., Margaret Gwynne, BA, Mary Culnane, MS, Ross E. Mckinney, Jr., MD, Sharon Nichols, PhD, Wendy G. Mitchell, MD, Ram Yogev, MD, Nancy Hutcheon, MD. Randomized Comparative Trial of Stavudine (d4T) versus Zidovudine (ZDV, AZT) in Children with Human Immunodeficiency Virus Infection. Pediatrics. 1998 Feb 01; 101(2):214-220.

Citation

Mirochnick M, Fenton T, Gagnier P, Pav J, Gwynne M, Siminski S, Sperling RS, Beckerman K, Jimenez E, Yogev R, Spector SA, Sullivan JL. Pharmacokinetics of Nevirapine in Human Immunodeficiency Virus type 1- Infected Pregnant Women and Their Neonates. Journal of Infectious Diseases. 1998 Aug 01; 178(2):368-74.

Citation

Walter T. Hughes, M.D., Alejandro Dorenbaum, M.D., Ram Yogev, M.D., B. Beauchamp, M.D., Jing Xu, M.S., James McNamara, M.D., John ( Jack ) Moye, Jr., M.D., Lynette Purdue, Pharm.D., Russell B. Van Dyke, M.D., Martha Rogers, M.D., Brian M. Sadler, Ph.D. A Phase I Safety and Pharmacokinetics Study of Micronized Atovaquone in Human Immunodeficiency Virus-infected Infants and Children. Antimicrobial Agents and Chemotherapy. 1998 Jun 01; 42(6):1315-18.